MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Superior cerebellar peduncles atrophy of PSP on PADRE imaging; comparison with idiopathic PD

    S. Kakeda, M. Miyata, T. Yoneda, S. Ide, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)

    Objective: The purpose of our study was to determine whether atrophy of Superior cerebellar peduncles (SCP) on phase-weighted magnetic resonance imaging technique (PADRE) was useful…
  • 2018 International Congress

    Neuromodulatory propensity of Ginko biloba to offset rotenone induced behaviour and biochemical alteration

    K. Rode, D. Khatri, M. Panchawadkar, P. Rane (Pune, India)

    Objective: The aim of present study was to evaluate neuromodulatory propensity of Gingko Biloba in rotenone induced Mice Model of Parkinson Disease in terms of…
  • 2018 International Congress

    Distinct abnormality of movement-related cortical potential between patients with Holmes tremor and cerebellar degeneration

    M.K. Lu, J.C. Chen, S.M. Liu, C.H. Tsai (Taichung, Taiwan)

    Objective: This study aims to investigate the role of cerebellum and the olivodentatorubral pathway in generating movement-related cortical potential (MRCP). Background: Cerebellum and its connecting…
  • 2018 International Congress

    The Impact of Vocal Fold Augmentation with Injection Laryngoplasty on Voice Quality in Patients with Parkinson Disease

    O. Klepitskaya, J. Barr, Y. Liu, S. Sillau, J. Litts, D. Fink, M. Shaffer, J. Newcombe, A. Klepitskaya, M. Clary (Aurora, CO, USA)

    Objective: To evaluate the effect of vocal fold injection augmentation with a temporary filler (carboxymethylcellulose gel) on voice and speech in Parkinson Disease (PD) patients…
  • 2018 International Congress

    Efficacy of opicapone in Parkinson’s disease patients with ‘early’ motor fluctuations: Responder analyses from the BIPARK-I double-blind experience

    J. Ferreira, A. Lees, W. Poewe, O. Rascol, A. Santos, E. Arbe, J-F. Rocha, P. Soares-da-Silva (Lisbon, Portugal)

    Objective: To evaluate, in levodopa-treated Parkinson’s Disease (PD) patients with ‘early’ motor fluctuations, the proportion of patients (ie, responders) achieving at least a 1-h reduction…
  • 2018 International Congress

    Gastric Retention of the Accordion Pill™: Results From MRI Studies With Parkinson’s Disease Patients and Healthy Volunteers

    N. Navon, R. Gendreau, J. Meckler (Jerusalem, Israel)

    Objective: To determine gastric retention (GR) of the Accordion Pill™ (AP) in patients with Parkinson’s disease (PD) and healthy volunteers. Background: While carbidopa/levodopa (CD/LD) is…
  • 2018 International Congress

    Treatment with levodopa/carbidopa intestinal gel of advanced Parkinson’s disease patients: Bulgarian experience

    E. Chorbadzhieva (Sofia, Bulgaria)

    Objective: To evaluate the efficacy of levodopa/carbidopa intestinal gel (LCIG) on motor fluctuations, dyskinesia, parkinson symptoms and quality of life in patients with late Parkinson’s…
  • 2018 International Congress

    Effects of High-frequency Repetitive Transcranial Magnetic Stimulation (HF-rTMS) Combined with Task Specific Training in Individuals with Parkinson’s Disease

    J. Thanakamchokchai, J. Tretriluxana, B. Fisher, N. Pakaprot, A. PisarnPong (Nakhon Pathom, Thailand)

    Objective: To examine the effects of HF-rTMS with reach-to-grasp (RTG) training focusing on the movement amplitude Background: Previous studies applied the HF-rTMS over primary motor…
  • 2018 International Congress

    Occurrence of dopaminergic adverse-events in patients that switched from entacapone to opicapone: The BIPARK-I open-label experience

    A. Ceballos-Baumann, K. Eggert, J. Ferreira, W. Poewe, O. Rascol, E. Arbe, J-F. Rocha, P. Soares-da-Silva (Munich, Germany)

    Objective: To assess the occurrence of dopaminergic adverse-events (AEs) in levodopa-treated Parkinson’s Disease (PD) patients that switched from entacapone (ENT) to opicapone (OPC) in the…
  • 2018 International Congress

    The possibility of medicamentous correction of the lower urinary tract dysfunction in patients with Parkinson’s disease

    M. Tukhtamishev, T. Khodjimetov, F. Akhmedova (Tashkent, Uzbekistan)

    Objective: The aim of the study was to correct the dyskinesia of the extremities, to study the efficacy and safety of drug therapy in men…
  • « Previous Page
  • 1
  • …
  • 54
  • 55
  • 56
  • 57
  • 58
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • Effect of marijuana on Essential Tremor: A case report
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley